LAUSR

Molnupiravir; molecular and functional descriptors of mitochondrial safety

Sign Up to like & get
recommendations!
1 Published in 2022 at "Toxicology and Applied Pharmacology"

DOI: 10.1016/j.taap.2022.116003

Abstract: Molnupiravir is an orally active nucleoside analog antiviral drug that recently was approved by the U.S. FDA for emergency treatment of adult patients infected with the SARS-CoV-2 (COVID-19) virus and at risk for severe progression.… read more here.

Keywords: molnupiravir molecular; molnupiravir; descriptors mitochondrial; functional descriptors ... See more keywords